Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1541157 · FYE Dec 31 · Prices AT CLOSE 2026-08-20 (USD) Last $7.79 · Day −1.39% · 1Y −79.5% · Off 52W high −84.3% · Vol (1Y) 297.6% Price2023-08-21 → 2026-08-20 AKTX close: $142 on 2023-08-21 to $8 on 2026-08-20. Split-adj closes · 240 of 2,743 · price returnⓘ At a glance | Short interest0.0% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)−0.00% | | Top-10 13F concentration100.0% | | Next report (est.)2026-11-26 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Earnings (TTM)-$31.0M | | ROE−68.4% | | ROIC−54.0% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−32.6% | | 1Y−79.5% | | 3Y−94.5% | | 5Y−99.4% | | 10Y−99.9% | | Since incept. (ann.)−52.3% |
Total return · from 2015-09-21ⓘ Risk | Ann. volatility (1Y)297.6% | | Ann. volatility (3Y)188.6% | | Sharpe (1Y)0.26 | | Sharpe (3Y)0.07 | | Max drawdown (1Y)−93.2% | | Max drawdown (3Y)−98.2% | | Beta (3Y vs SPY)1.57 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| ARMISTICE CAPITAL, LLC | 38,922 | $200,448 | 0.00% | −98.6% | | Cresset Asset Management, LLC | 20,561 | $105,889 | 0.00% | −97.5% | | IFP Advisors, Inc | 7,431 | $1,809 | 0.00% | new | | SBI Securities Co., Ltd. | 5 | $26 | 0.00% | −97.5% | | MORGAN STANLEY | 1 | $5 | 0.00% | −66.7% | | Truvestments Capital LLC | 1 | $5 | 0.00% | −98.0% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-13 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-13 | $0.00 | — | — | — | | 2026-03-31 | 2026-05-19 | $0.00 | — | — | — | | 2025-09-30 | 2025-11-13 | $0.00 | — | — | — | | 2025-06-30 | 2025-08-13 | $0.00 | — | — | — |
As-reported XBRL · next 2026-11-26 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
